(Q4712362)

DrugBank

parenteral route of administration

17 November 2015

5.7 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=A10BJ04

active ingredient in

Eperzan

1 reference

European Medicines Agency product number

EMEA/H/C/002735

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002735/human_med_001735.jsp

medical condition treated

22 March 2017

type-1 diabetes

1 reference

Drug Indications Extracted from FAERS

2 October 2018

glucose intolerance

1 reference

Drug Indications Extracted from FAERS

imported from Wikimedia project

2 October 2018

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Albiglutide

10 March 2019

1 reference

Albiglutide (English)

DrugBank

17 November 2015

1 reference

Medical Subject Headings

15 March 2018

C78128

1 reference

UNII

5E7U48495E

14 February 2018

Identifiers

2 references

Albiglutide (English)

publication date

17 November 2015

reason for deprecated rank

14 February 2018

deprecated identifier value

0 references

0 references

1 reference

Hazardous Substances Data Bank

Albiglutide (English)

19 January 2016

1 reference

28 October 2019

Albiglutide (English)

10 May 2021

0 references

1 reference

Guide to Pharmacology Ligand ID

Albiglutide (English)

publication date

17 November 2015

A10BJ04

0 references

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

14 February 2018

0 references

2 references

ALBIGLUTIDE (English)

19 January 2016

UNII

5E7U48495E

MedlinePlus drug identifier

14 February 2018

a614031

0 references

PatientsLikeMe treatment ID

0 references

1 reference

ALBIGLUTIDE (English)

19 January 2016

1 reference